CFB
AUPH icon

Cullen/Frost Bankers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cullen/Frost Bankers’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Buy
+1,705
New +$27.2K ﹤0.01% 991

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Cullen/Frost Bankers's AUPH Position: Q2 2026 in Review

Cullen/Frost Bankers opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 1,705 shares worth $28.9K. The stake represents ﹤0.01% of the portfolio and ranks #991 among its holdings.

48 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Cullen/Frost Bankers held 1,705 shares of Aurinia Pharmaceuticals worth $28.9K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Cullen/Frost Bankers position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #991 holding.
  • 48 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.